Diagnostic performance of Prof. Valmed, ChatGPT-5 Thinking, and OpenEvidence in rheumatology: A comparative evaluation

Read full text
Authors: Phillip Kremer, Emily Langballe, Isabell Haase, Jonathan Bamberger, Sebastian Kühn, Martin Krusche, Johannes Knitza
Cited by: 12
References: 28

Abstract

To compare the diagnostic performance of a subscription-based medical large language model (LLM) certified as a medical device (Prof. Valmed), a subscription-based general-purpose LLM (ChatGPT-5 Thinking), and a freely accessible medical LLM (OpenEvidence). Sixty vignettes covering rare rheumatic diseases and differential diagnoses were entered using a standardized prompt to generate five top diagnoses and respective diagnostic probabilities. Blinded rheumatologists categorized suggested diagnoses as identical, plausible, or diagnostically different. Diagnostic accuracy was assessed using proportions of identical and plausible diagnoses and a total diagnostic score. Analyses were descriptive. Group differences for the proportion of identical top diagnoses were explored using Cochran’s Q test and post-hoc McNemar tests. Processing time was recorded. OpenEvidence produced the highest proportion of identical top diagnoses (35.0%), followed by ChatGPT-5 Thinking (26.7%) and Prof. Valmed (23.3%); however, pairwise differences were not statistically significant. ChatGPT-5 Thinking achieved the highest total diagnostic score (226), followed by OpenEvidence (221) and Prof. Valmed (212). All systems showed markedly higher diagnostic probabilities for identical versus different diagnoses. Mean processing times ranged from 20 to 36 s. All three systems demonstrated broadly comparable diagnostic accuracy and processing times. Further benchmarking that incorporates additional evaluation dimensions is essential to inform safe and effective use of LLM-based clinical support.

Fields of Study & Subjects

Artificial Intelligence in Healthcare and Education Clinical Reasoning and Diagnostic Skills Rheumatoid Arthritis Research and Therapies

Publication details

Journal / source
Rheumatology International
Publisher
Springer Science and Business Media LLC
Volume
46
Issue
1
Pages
31–31
Publication date
10 January 2026
Language
EN